J Cancer 2018; 9(6):959-967. doi:10.7150/jca.22787

Research Paper

Increased Paxillin expression in prostate cancer is associated with advanced pathological features, lymph node metastases and biochemical recurrence

Qing-Shui Zheng1*, Shao-Hao Chen1*, Yu-Peng Wu1*, Hui-Jun Chen1, Hong Chen2, Yong Wei1, Xiao-Dong Li1, Jin-Bei Huang1, Xue-Yi Xue1✉, Ning Xu1✉

1. Departments of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
2. Departments of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
* Contributed equally

Abstract

Purpose Paxillin regulates cell-cell adhesion, and altered Paxillin expression has been associated with human carcinogenesis. This study analyzed the association between Paxillin expression in prostate cancer (PCa) tissues with clinicopathological features, lymph node metastasis and biochemical PCa recurrence.

Methods A total of 386 tissue specimens from PCa patients who received radical prostatectomy and 60 tissue specimens from benign prostatic hyperplasia (BPH) cases were collected to construct tissue microarrays, which were subsequently immunostained for Paxillin expression. Thirty positive lymph node tissue specimens and 10 healthy prostate tissue specimens were randomly selected for Paxillin immunostaining.

Results The association between Paxillin expression, lymph node metastasis and biochemical PCa recurrence was analyzed. Paxillin expression was significantly higher in PCa than both normal and BPH tissues (P<0.001) and was correlated with preoperative prostate-specific antigen level, Gleason score, clinical tumor stage, lymph node metastasis, positive surgical margin, extracapsular extension and seminal vesicle invasion (P<0.05 for all). Logistic regression analysis showed that Paxillin and Gleason score were independent risk factors for PCa lymph node metastasis (P<0.05). The receiver operating characteristic (ROC) curve indicated that Paxillin expression (AUC=0.723) more accurately predicted PCa lymph node metastasis than Gleason score (AUC=0.692). Kaplan-Meier curve analysis showed that increased Paxillin expression was associated with shortened biochemical-free survival (BFS) after radical prostatectomy (P<0.001).

Conclusion Paxillin was significantly upregulated in PCa compared with BPH and normal tissues and associated with lymph node metastasis and shortened BFS of PCa. Further study will investigate the underlying molecular mechanism and the role of Paxillin in PCa.

Keywords: paxillin, prostate cancer, lymph node metastasis, pathological feature, biochemical-free survival, prediction

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Zheng QS, Chen SH, Wu YP, Chen HJ, Chen H, Wei Y, Li XD, Huang JB, Xue XY, Xu N. Increased Paxillin expression in prostate cancer is associated with advanced pathological features, lymph node metastases and biochemical recurrence. J Cancer 2018; 9(6):959-967. doi:10.7150/jca.22787. Available from http://www.jcancer.org/v09p0959.htm